Date published: 2026-3-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADAR2 Activators

ADAR2 Activators, also known as Adenosine Deaminase Acting on RNA 2 Activators, belong to a class of molecules that play a pivotal role in the regulation of RNA editing processes within living organisms. These activators are characterized by their ability to enhance the enzymatic activity of ADAR2, an enzyme that catalyzes the deamination of adenosine (A) to inosine (I) in double-stranded RNA (dsRNA) molecules. This RNA editing process is essential for fine-tuning the functional diversity of RNA transcripts, thereby influencing gene expression and protein function. ADAR2, one of the three ADAR (Adenosine Deaminase Acting on RNA) enzymes found in humans, predominantly targets neural tissues and plays a vital role in neural development and function. Activating ADAR2 can lead to increased efficiency in the deamination process, resulting in the conversion of adenosines to inosines more frequently and with greater specificity.

The mechanism of ADAR2 activation involves interactions between the activators and the enzyme's catalytic domain, ultimately enhancing its binding affinity to dsRNA substrates. This heightened binding affinity allows ADAR2 to access its target sites more effectively, leading to increased RNA editing activity. The precise structural and chemical properties of ADAR2 activators may vary, but they are generally designed to modulate the conformational changes in the enzyme's active site or stabilize its interaction with dsRNA. Understanding the mechanisms and molecular structures of these activators is crucial for elucidating the fundamental processes of RNA editing and its implications in various biological contexts, such as neural function and development. Researchers continue to investigate ADAR2 activators to gain deeper insights into their mechanisms and applications, including the development of tools for studying RNA editing and its consequences on cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

As an HDAC inhibitor, sodium butyrate may increase transcription of ADAR2 by affecting chromatin structure.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium influences several signaling pathways that could include upregulation of ADAR2 expression in the central nervous system.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Cholecalciferol modulates gene expression and may enhance ADAR2 expression as part of its neuroprotective roles.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

As a SIRT1 activator, resveratrol could affect ADAR2 expression through epigenetic mechanisms.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates cAMP pathways, which could lead to the upregulation of ADAR2 expression.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

As a glucocorticoid, dexamethasone can affect RNA editing mechanisms and potentially ADAR2 expression.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

DL-Sulforaphane may exert epigenetic effects that induce ADAR2 expression via antioxidant response pathways.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor may upregulate ADAR2 by demethylating its promoter region.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic acid is another HDAC inhibitor that might increase ADAR2 expression through epigenetic changes.